Skip to search formSkip to main contentSkip to account menu

NSC-26271

Known as: NSC 26271, NSC26271 
National Institutes of Health

Related topics

Related topics

3 relations
Altretamine/cisplatin/cyclophosphamide/doxorubicin protocolB-518

Broader (1)

Cyclophosphamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1980
1980
Treatment of advanced colon cancer with 5‐fluorouracil (NSC19893) versus cyclophosphamide (NSC26271) plus 5‐fluorouracil. Prognostic aspects of the differential white blood cell count
One hundred twenty‐one patients with advanced measurable adenocarcinoma of the colon were randomized for treatment with… 
1976
1976
Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial.
One hundred and nine adult patients with metastatic carcinoma were treated at 3-4-week intervas with a combination of adriamycin… 
1976
1976
Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
The permeation kinetics of cyclophosphamide and its metabolites were studied with Ehrlich ascites tumor cells, murine L1210… 
1976
1976
Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
: In a randomized study, 35 patients with advanced-stage epithelial ovarian cancers with progressive disease after prior single… 
1976
1976
Some studies on the distribution and effects of cyclophosphamide (NSC-26271) in normal and neoplastic tissue.
The gross uptake and intracellula distribution of 32P-cyclophosphamide has been studied in normal and neoplastic rat and mouse… 
1976
1976
Studies on the selective action of cyclophosphamide (NSC-26271): Inactivation of the hydroxylated metabolite by tissue-soluble enzymes.
The hypothesis that selective action of cyclophosphamide, compared to other nitrogen mustards, is due to a balance between… 
1976
1976
Bleomycin (NSC-125066) followed by cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and 5-fllorouracil (NSC-19893) for non-oat cell bronchogenic carcinoma.
The in vivo observation that bleomycin may be used as a synchronizing agent provides the basis for testing 4 days of continuous… 
1976
1976
Biologic activity of two derivatives and six possible metabolites of cyclophosphamide (NSC-26271).
The biologic activity in terms of survival of normal hematopoietic stem, osteosarcoma, and L1210 leukemia cells was determined… 
1975
1975
Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271).
Thirteen of 29 patients with acute nonlymphoblastic leukemia achieved complete remission with cyclophosphamide, cytosine… 
1975
1975
Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in combination with cyclophosphamide (NSC-26271) in the treatment of human malignancies.
: The effectiveness of cis-dichlorodiammineplatinum(II) in the treatment of human malignancies is evaluated. The first stage of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)